MRPL3 and pancreatic adenocarcinoma: Survival analysis demonstrated that high MRPL3 expression was associated with shorter DFS (hazard ratio [HR] = 1.90, 95% confidence interval [CI] = 1.28-2.18, p = 0.001) and OS (HR = 1.95, 95% CI = 1.27-2.97, p = 0.002) in TCGA-PAAD, as well as with poorer OS (HR = 1.55, 95% CI = 1.01-2.38, p = 0.044) in GSE183795 (Figure 2C-E).